Abbas S, Bissett I P, Parry B R
Surgery, University of Auckland, Parks Road, Auckland, New Zealand, 1.
Cochrane Database Syst Rev. 2005 Jan 25(1):CD004651. doi: 10.1002/14651858.CD004651.pub2.
Adhesions are the leading cause of small bowel obstruction. Most adhesive small bowel obstructions resolve following conservative treatment but there is no consensus as to when conservative treatment should be considered unsuccessful and the patient should undergo surgery. Studies have shown that failure of an oral water-soluble contrast to reach the colon after a designated time indicates complete intestinal obstruction that is unlikely to resolve with conservative treatment. Other studies have suggested that the administration of water-soluble contrast is therapeutic in resolving the obstruction.
The aims of this review are:1. To determine the reliability of water-soluble contrast media and serial abdominal radiographs in predicting the success of conservative treatment in patients admitted with adhesive small bowel obstruction.2. To determine the efficacy and safety of water-soluble contrast media in reducing the need for surgical intervention and reducing hospital stay in adhesive small bowel obstruction.
The search was conducted using MeSH terms: ''Intestinal obstruction'', ''water-soluble contrast'', "Adhesions" and "Gastrografin", and combined with the Cochrane Collaboration highly sensitive search strategy for identifying randomised controlled trials and controlled clinical trials.
The appearance of water-soluble contrast in the caecum on an abdominal radiograph within 24 hours of its administration predicts resolution of an adhesive small bowel obstruction with a pooled sensitivity of 0.96, specificity of 0.96. The area under the curve of the summary ROC was 0.98. Four randomised studies dealing with the therapeutic role of Gastrografin were included in the review, water-soluble contrast did not reduce the need for surgical intervention (odds ratio 1.29, P = 0.36). Meta-analysis of two studies showed that water-soluble contrast reduced hospital stay compared with placebo (weighted mean difference = - 2.58) P = 0.004.
AUTHORS' CONCLUSIONS: Published literature strongly supports the use of water-soluble contrast as a predictive test for non-operative resolution of adhesive small bowel obstruction. Although Gastrografin does not cause resolution of small bowel obstruction, it does appear to reduce hospital stay.
粘连是小肠梗阻的主要原因。大多数粘连性小肠梗阻经保守治疗可缓解,但对于何时应认为保守治疗失败以及患者应接受手术,尚无共识。研究表明,口服水溶性造影剂在指定时间后未到达结肠表明存在完全性肠梗阻,不太可能通过保守治疗缓解。其他研究表明,给予水溶性造影剂对解除梗阻具有治疗作用。
本综述的目的是:1. 确定水溶性造影剂和系列腹部X线片在预测粘连性小肠梗阻患者保守治疗成功方面的可靠性。2. 确定水溶性造影剂在减少粘连性小肠梗阻手术干预需求和缩短住院时间方面的疗效和安全性。
检索使用了医学主题词:“肠梗阻”、“水溶性造影剂”、“粘连”和“泛影葡胺”,并结合Cochrane协作网高度敏感的检索策略来识别随机对照试验和对照临床试验。
水溶性造影剂给药后24小时内腹部X线片上盲肠出现造影剂,预测粘连性小肠梗阻缓解的汇总敏感性为0.96,特异性为0.96。汇总ROC曲线下面积为0.98。本综述纳入了四项涉及泛影葡胺治疗作用的随机研究,水溶性造影剂并未减少手术干预的需求(优势比1.29,P = 0.36)。两项研究的荟萃分析表明,与安慰剂相比,水溶性造影剂缩短了住院时间(加权平均差=-2.58),P = 0.004。
已发表的文献有力支持使用水溶性造影剂作为粘连性小肠梗阻非手术缓解的预测性检查。虽然泛影葡胺不能解除小肠梗阻,但它似乎确实缩短了住院时间。